Oruka Therapeutics Inc. Common Stock vs Trane Technologies plc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 20.3× Oruka Therapeutics Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ORKA | TT | |
|---|---|---|
Market Cap | $5.18B | $105.17B |
Volume | 490,798 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $113.08 | $503.46 |
52-Week Low | $26.19 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $4.31B | $108.47B |
Dividend Yield | — | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →